Upcoming Events of Interest
There are a number of upcoming events of interest to the legal reform community.
There are a number of upcoming events of interest to the legal reform community.
Sen. Robert Singer (R-Lakewood) has introduced a bill that would allow plaintiffs suffering from mesothelioma and their family members to file personal injury and wrongful death lawsuits at any time after the disease is diagnosed. If this bill is passed, it would make New Jersey a magnet for asbestos litigation.
A selection of the need-to-know civil justice news for the week of August 8-14.
On August 11, the Appellate Division issued an important ruling in the ongoing litigation over Hoffmann-La Roche Ltd.’s acne medication Accutane. The decision by appellate judges Sabatino, Simonelli, and Leone overturns a $25 million+ verdict from a 2010 jury trial, and brings to a close a case that has been bogging down the court system for over a decade. It also sends a clear message that some choice of law questions are no longer open for debate.
This morning the Appellate Division issued an important ruling in the ongoing litigation over Hoffmann-La Roche Ltd.’s acne medication Accutane. The ruling brings to a close a case that has been bogging down the court system for over a decade, and sends a clear message that some choice of law questions are no longer open for debate.
A selection of the need-to-know civil justice news for the week of August 1-7.
Delaware has dominated the business law scene for decades, but a recent move by its legislature has companies considering moving their legal issues, and thus their business, elsewhere. Delaware’s stumble could be an opportunity for New Jersey to woo businesses to the Garden State.
A selection of the need-to-know civil justice news for the [...]
This week the American Bar Association is holding its annual meeting in Chicago. Thanks to NJCJI and other pro-defense attorneys and organizations the ABA will not be voting on a controversial resolution (link) that would have put the ABA on record as “oppos[ing] legislation that limits and/or bans punitive damages for claims of patient harm allegedly caused by manufacturers of FDA-approved medical products or devices.”
Did you know that New Jersey lawyers are 70% more likely than their counterparts nationwide to file a claim with their malpractice insurer? Even attorneys practicing in our notoriously litigious neighboring states face fewer malpractice claims. This suggests that one of two things is going on. Either New Jersey attorneys are awful, or there is something about our legal system that is encouraging excessive litigation. Data provided to the New Jersey Civil Justice Institute by CNA insurance suggests that the latter reason is more likely to blame for the high number of malpractice claims filed in the Garden State.